Modulators of Toll-Like Receptors
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 7 of these applications claim priority to application 61/121,061, filed Dec 9, 2008. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 8,629,142 | Modulators of Toll-Like Receptors In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | ||
| US 8,809,527 | Modulators of Toll-Like Receptors In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | ||
| US 9,127,006 | Modulators of Toll-Like Receptors In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | ||
| US 9,452,166 | Modulators of Toll-Like Receptors In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | ||
| US 10,172,860 | Modulators of Toll-Like Receptors In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | ||
| US 11,110,091 | Modulators of Toll-Like Receptors In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | ||
| US 8,367,670 | Modulators of Toll-Like Receptors In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | ||
| Application 15/244,943 | Modulators of Toll-Like Receptors Abandoned Abandoned Aug 21, 2017 | Gilead Sciences, Inc. | Abandoned | Abandoned Aug 21, 2017 |
8 of 8 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
7 of these are in force and held by Gilead Sciences, Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.